Showing results 1 to 6 of 6
| Title | Author(s) | Issue Date | |
|---|---|---|---|
A longitudinal environmental surveillance study for SARS-CoV-2 from the emergency department of a teaching hospital in Hong Kong Journal:Journal of Hospital Infection | 12-Jun-2023 | ||
Antibody effector function and T cell reponses to homologous and heterologous inactivated or mRNA vaccines against SARS-CoV-2 Proceeding/Conference:Correlates of Protection for Next Generation Influenza Vaccines: Lessons learned from the COVID pandemic (01/03/2023-03/03/2023, Seattle) | 3-Mar-2023 | ||
| 2019 | |||
Homologous and heterologous boosting with third-dose BNT162b2 and CoronaVac: a randomized trial (Cobovax study) Proceeding/Conference:Options for the Control of Influenza XI | 2022 | ||
| 2020 | |||
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro Journal:Antiviral Research | 2020 |